175 related articles for article (PubMed ID: 25908454)
1. Knockdown of c-MET induced apoptosis in ABCB1-overexpressed multidrug-resistance cancer cell lines.
Hung TH; Li YH; Tseng CP; Lan YW; Hsu SC; Chen YH; Huang TT; Lai HC; Chen CM; Choo KB; Chong KY
Cancer Gene Ther; 2015 May; 22(5):262-70. PubMed ID: 25908454
[TBL] [Abstract][Full Text] [Related]
2. FZD1 activates protein kinase C delta-mediated drug-resistance in multidrug-resistant MES-SA/Dx5 cancer cells.
Hung TH; Chen CM; Tseng CP; Shen CJ; Wang HL; Choo KB; Chong KY
Int J Biochem Cell Biol; 2014 Aug; 53():55-65. PubMed ID: 24814288
[TBL] [Abstract][Full Text] [Related]
3. Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway.
Hung TH; Hsu SC; Cheng CY; Choo KB; Tseng CP; Chen TC; Lan YW; Huang TT; Lai HC; Chen CM; Chong KY
Oncotarget; 2014 Dec; 5(23):12273-90. PubMed ID: 25401518
[TBL] [Abstract][Full Text] [Related]
4. Stable suppression of MDR-1 gene using siRNA expression vector to reverse drug resistance in a human uterine sarcoma cell line.
Hua J; Mutch DG; Herzog TJ
Gynecol Oncol; 2005 Jul; 98(1):31-8. PubMed ID: 15921732
[TBL] [Abstract][Full Text] [Related]
5. Wnt pathway activation and ABCB1 expression account for attenuation of proteasome inhibitor-mediated apoptosis in multidrug-resistant cancer cells.
Chong KY; Hsu CJ; Hung TH; Hu HS; Huang TT; Wang TH; Wang C; Chen CM; Choo KB; Tseng CP
Cancer Biol Ther; 2015; 16(1):149-59. PubMed ID: 25590413
[TBL] [Abstract][Full Text] [Related]
6. Blockade of c-Met-Mediated Signaling Pathways by E7050 Suppresses Growth and Promotes Apoptosis in Multidrug-Resistant Human Uterine Sarcoma Cells.
Huang TT; Chen CM; Lan YW; Lin SS; Choo KB; Chong KY
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499211
[TBL] [Abstract][Full Text] [Related]
7. Hexane fraction of adlay (Coix lachryma-jobi L.) testa ethanolic extract inhibits human uterine sarcoma cancer cells growth and chemosensitizes human uterine sarcoma cells to doxorubicin.
Chang CC; Huang LH; Chiang W; Hsia SM
Phytomedicine; 2018 Aug; 47():69-80. PubMed ID: 30166110
[TBL] [Abstract][Full Text] [Related]
8. Anticancer effects of a specific mixture of nutrients in the multidrug-resistant human uterine sarcoma MES-SA/Dx5 and the drug-sensitive MES-SA cell lines.
Roomi MW; Kalinovsky T; Roomi NW; Rath M; Niedzwiecki A
Oncol Rep; 2012 Jan; 27(1):17-27. PubMed ID: 21947138
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1.
Yang G; Wu D; Zhu J; Jiang O; Shi Q; Tian J; Weng Y
Oncol Rep; 2013 Aug; 30(2):877-89. PubMed ID: 23760062
[TBL] [Abstract][Full Text] [Related]
10. Psammaplin A induces Sirtuin 1-dependent autophagic cell death in doxorubicin-resistant MCF-7/adr human breast cancer cells and xenografts.
Kim TH; Kim HS; Kang YJ; Yoon S; Lee J; Choi WS; Jung JH; Kim HS
Biochim Biophys Acta; 2015 Feb; 1850(2):401-10. PubMed ID: 25445714
[TBL] [Abstract][Full Text] [Related]
11. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of c-Met inhibits cell proliferation and invasion and increases chemosensitivity to doxorubicin in human multiple myeloma U266 cells in vitro.
Que W; Chen J
Mol Med Rep; 2011; 4(2):343-9. PubMed ID: 21468575
[TBL] [Abstract][Full Text] [Related]
13. A 20(S)-protopanoxadiol derivative overcomes multi-drug resistance by antagonizing ATP-binding cassette subfamily B member 1 transporter function.
Chen G; Liu J; Chen W; Xu Q; Xiao M; Hu L; Mao L; Wang X
Oncotarget; 2016 Feb; 7(8):9388-403. PubMed ID: 26824187
[TBL] [Abstract][Full Text] [Related]
14. A novel anthracene derivative, MHY412, induces apoptosis in doxorubicin-resistant MCF-7/Adr human breast cancer cells through cell cycle arrest and downregulation of P-glycoprotein expression.
De U; Chun P; Choi WS; Lee BM; Kim ND; Moon HR; Jung JH; Kim HS
Int J Oncol; 2014 Jan; 44(1):167-76. PubMed ID: 24190517
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
[TBL] [Abstract][Full Text] [Related]
16. Gα12 overexpressed in hepatocellular carcinoma reduces microRNA-122 expression via HNF4α inactivation, which causes c-Met induction.
Yang YM; Lee CG; Koo JH; Kim TH; Lee JM; An J; Kim KM; Kim SG
Oncotarget; 2015 Aug; 6(22):19055-69. PubMed ID: 25965999
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-34a overcomes HGF-mediated gefitinib resistance in EGFR mutant lung cancer cells partly by targeting MET.
Zhou JY; Chen X; Zhao J; Bao Z; Chen X; Zhang P; Liu ZF; Zhou JY
Cancer Lett; 2014 Sep; 351(2):265-71. PubMed ID: 24983493
[TBL] [Abstract][Full Text] [Related]
18. The HGF inhibitory peptide HGP-1 displays promising in vitro and in vivo efficacy for targeted cancer therapy.
Chen L; Li C; Zhu Y
Oncotarget; 2015 Oct; 6(30):30088-101. PubMed ID: 26254225
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer-derived bone metastasis can be effectively reduced through specific c-MET inhibitor tivantinib (ARQ 197) and shRNA c-MET knockdown.
Previdi S; Abbadessa G; Dalò F; France DS; Broggini M
Mol Cancer Ther; 2012 Jan; 11(1):214-23. PubMed ID: 22027690
[TBL] [Abstract][Full Text] [Related]
20. Human sarcoma cell lines MES-SA and MES-SA/Dx5 as a model for multidrug resistance modulators screening.
Wesolowska O; Paprocka M; Kozlak J; Motohashi N; Dus D; Michalak K
Anticancer Res; 2005; 25(1A):383-9. PubMed ID: 15816562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]